Contact Us
Plans and Services Health and Wellness About Wellmark Member Employer Producer Provider
Home Health and Wellness Drug Information
» Talk to a Nurse
» Wellness Assessment
» Health Support
» Preventive Care
» Choose Care Wisely
» Find a Doctor or Hospital
» Drug Information
printer friendly Printer-Friendly Page
Updates to the Wellmark Drug List

Twice a year a committee of statewide pharmacists and physicians reviews the Wellmark Drug List of covered drugs with the intent of reducing costs for members. Sometimes the cost share, such as copayments and deductibles, for certain drugs may change. On July 31, 2015, the following changes will be made to the Wellmark Drug List.

 

If you have any questions about your prescription drug coverage, please contact your pharmacist and or the prescribing physician. For additional questions, please contact Wellmark Customer Service at the number on the back of your ID card.

 

Wellmark Formulary Changes for July 31, 2015

Drugs moving to the highest tier or non-formulary

Actoplus Met XR

Cambia

Menest

Android

Elidel

Nasonex

Apidra

Femring

Proventil HFA

Avandia

Gralise

Ventolin HFA

Bethkis

Horizant

Vimovo

Binosto

Humalog/Humalog Mix

 

Brisdelle

Humulin

 

 

Drugs moving to a lower Tier

Advair Diskus, moving to tier 2

Jentadueto, moving to tier 2

Advair HFA, moving to tier 2

Levemir, moving to tier 2

Asmanex HFA, moving to tier 1

Levemir Flexpen, moving to tier 2

Astagraf XL, moving to tier 2

Levemir Flextouch, moving to tier 2

Eliquis, moving to tier 2

Pradaxa, moving to tier 2

Janumet, moving to tier 2

Tradjenta, moving to tier 2

Janumet XR, moving to tier 2

Victoza, moving to tier 2

 

Drugs moving from Tier 1 to Tier 2

Estrace

 

Drugs moving from Tier 2 to Tier 3

Byetta

Elmiron

Epzicom

Multaq

Tikosyn

Ranex

 

Drugs moving from Tier 3 to Preferred Specialty

Kuvan

 

Drugs not covered

First-Omeprazole

Fluoride Products

 

 



Related Information
»   Locate a Pharmacy open new window image
»   Download Forms
»   Prior Authorization open new window image
»   Quantity Limits open new window image
FacebookTwitterInstagrampinterestLinked InYou Tube